AFYREN
Biotech company producing natural organic acids and derivatives via transformation of non-food biomass AFYREN industrialise au niveau mondial des procédés innovants dans le but de produire sans déchets des molécules naturelles habituellement pétro-sourcées, servant à fabriquer les produits du quotidien (alimentation, cosmétique, agronomie), tout en respectant l’environnement. La biomasse non-alimentaire …
[voir plus]
Amolyt Pharma
Advancing peptides for the treatment of rare endocrine and metabolic disorders Amolyt Pharma is building on its team’s established expertise in therapeutic peptides development to deliver life-changing treatments to patients suffering from rare endocrine and metabolic diseases. Amolyt Pharma’s portfolio includes AZP-3601, a parathyroid hormone analog for the potential treatment …
[voir plus]
BioSerenity
BioSerenity is a medical device company focused on developing smart healthcare solutions. Our first product is the Neuronaute, a mobile EEG system using smart clothing that allows for long term monitoring of EEG signals in order to help with the diagnosis of epilepsy. We are now working on Cardiology, Urology, …
[voir plus]
DNA Script
Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAX™️, the world’s …
[voir plus]
Dreem
The virtual clinic making great sleep accessible, to all. Traditionally, sleep care has been costly & complicated. No more. With leading science, cutting edge technology and personalized care, we are reshaping sleep care to make it accessible — to all.
[voir plus]
Dynacure
Dynacure is a clinical-stage company focused on developing novel therapies for rare diseases. Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate …
[voir plus]
Enterome
Microbiome Decoded - Healthcare Transformed We are a clinical stage biopharmaceutical company developing first in class drugs based on our unique ability to de-code molecular interactions in the gut microbiome impacting human health. We have developed two highly promising pipelines of clinical and pre-clinical candidates with a focus on cancer …
[voir plus]
ENYO Pharma
ENYO Pharma est une entreprise au stade clinique ayant une approche innovante inspirée par les virus. Notre biotech imite les stratégies virales permettant ainsi de moduler les fonctions cellulaires pour des indications thérapeutiques variées. Nous développons de nouveaux médicaments candidats dans plusieurs indications telles que les maladies infectieuses (par exemple …
[voir plus]
EVerZom
The CDMO for extracellular vesicle and exosome manufacturing. EverZom is a nanomedecine biotech companies developing a GMP compliant extracellular vesicle manufacturing platform based on a unique proprietary technology for pharmaceutical researchers developing breakthrough biotherapies. Extracellular vesicles which encompass exosomes, microvesicles and apoptotic bodies are the tools used by cells to …
[voir plus]
EYEVENSYS
We create ophthalmic therapeutic bio factories to sustainably treat major eye diseases. Eyevensys is a clinical stage, private, biotechnology company developing its innovative EyeCET platform to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic disease. EyeCET stands for the eye ciliary muscle electro-transfection …
[voir plus]
GAIAGO
We believe that Mankind thrives when Soils thrive. We aim to become world leader in Soils revitalization 🚀#hiring 🚀 GAIAGO is an Agtech company based in the region of St Malo, France. Only healthy Soils allow abundant and quality food production. We produce a new generation of Soil improvements tools, …
[voir plus]
Green Spot Technologies
Challenging the food waste paradigm to feed the future // French Tech Agri20 Green Spot Technologies (GST) est une jeune entreprise innovante, nous produisons des ingrédients upcyclés et fermentés pour permettre aux fabricants de produits alimentaires de séduire les consommateurs modernes. Au départ, la société a été créée en 2016 …
[voir plus]
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, …
[voir plus]
Inotrem
Control innate immunity Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock. Founded in 2013, with offices in Paris and a technology center in Nancy (France), the company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced …
[voir plus]
Micropep Technologies
Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins.
[voir plus]
Microphyt
Fostering a Blue Future ! Des solutions uniques puisées au cœur des microalgues. Créée en 2007 près de Montpellier-France, Microphyt développe et commercialise des ingrédients bioactifs uniques issus de microalgues. Pour cela la société utilise des technologies et des procédés de pointe. Développés depuis plus de 10 ans et approuvés …
[voir plus]
Mnemo Therapeutics
Mnemo Therapeutics is a biotechnology company focused on discovering and developing immune based therapies, including powerful cell therapies, that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of …
[voir plus]
Nosopharm
Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR). The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs. The innovative anti-infective drug discovery platform developed by Nosopharm …
[voir plus]
Osivax
Pioneering A New Class of Universal Vaccines Osivax’ mission is to develop “universal” vaccines against highly-mutating viruses. Leveraging its unique oligoDOM® technology platform, OSIVAX is developing a universal vaccine for both current and future influenza infections. The Company’s universal flu vaccine candidate, OVX836 is in Phase 2a clinical development. OSIVAX …
[voir plus]
Pherecydes Pharma
At the forefront of the fight against antibioresistant bacteria Pherecydes Pharma develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on eukaryotic cells, including human …
[voir plus]
Poietis
Make tissues real Poietis (gr. Ποίησις: to make). "The one who makes things real." Poietis develops and produces human, customized tissues using 4D bioprinting for pharmaceutical and cosmetic applications as well as regenerative medicine. Complex 3D tissues are obtained by high resolution Laser-Assisted Bioprinting.
[voir plus]
Qubit Pharmaceuticals
Accelerating drug discovery with quantum physics and high performance computing Accelerating drug discovery with quantum physics and high performance computing
[voir plus]
Smart Immune
Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage biotechnology company developing ProTcell™, a thymus-empowered cell therapy platform to fully and rapidly re-arm the immune system, enabling next-generation allogeneic T-cell therapies for all. The company was founded in 2017 to help patients with life-threatening diseases …
[voir plus]
StemInov
Births can save lives StemInov is a French Drug Discovery company working on a innovative cell based therapy in immunology
[voir plus]
TISSIUM
Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, …
[voir plus]
TreeFrog Therapeutics
Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant …
[voir plus]
Ÿnsect
The world leader in insect ingredient production: a natural, healthy and sustainable solution to feed the world. #BCorp Ÿnsect is the world leader in the production of protein and natural insect fertilizers. Founded in 2011 in Paris, France, by both scientists and environmental activists, Next40 and B Corp-certified, the company …
[voir plus]